Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PENTAMIDINE DIISETIONATE CRS (30 MG)

PENTAMIDINE DIISETIONATE CRS (30 MG)

140-64-7

DISCOVER
PENTAZOCINE - REFERENCE SPECTRUM (N/A)

PENTAZOCINE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
PENTAZOCINE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

PENTAZOCINE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Phosphoserine-L-O

Phosphoserine-L-O

407-41-0

DISCOVER
PENTOBARBITAL CRS - * PSY (100 MG)

PENTOBARBITAL CRS - * PSY (100 MG)

76-74-4

DISCOVER
PENTOXIFYLLINE CRS (100 MG)

PENTOXIFYLLINE CRS (100 MG)

06/05/6493

DISCOVER
PEPSIN POWDER  BRP (2000 MG)

PEPSIN POWDER BRP (2000 MG)

9001-75-6

DISCOVER
PERPHENAZINE CRS (100 MG)

PERPHENAZINE CRS (100 MG)

58-39-9

DISCOVER
PETHIDINE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

PETHIDINE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

ND

DISCOVER
PETHIDINE IMPURITY A CRS (20 MG)

PETHIDINE IMPURITY A CRS (20 MG)

ND

DISCOVER
PHENAZONE CRS (20 MG)

PHENAZONE CRS (20 MG)

60-80-0

DISCOVER
PHENIRAMINE MALEATE CRS (250 MG)

PHENIRAMINE MALEATE CRS (250 MG)

132-20-7

DISCOVER